TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34953185

Group type: EXPERIMENTAL
Intervention: Ketoprofen lysine salt solution
Number of subjects: 100

Group type: COMPARATOR
Intervention: Native vitamin D prescriptions
Number of subjects: 100
Study: 33878069

Group type: EXPERIMENTAL
Intervention: Fibular nail
Number of subjects: 125

Group type: COMPARATOR
Intervention: Plate fixation
Number of subjects: 125
Study: 33177243

Group type: EXPERIMENTAL
Intervention: Increasing years of schooling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically elevated HDL cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted total cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted LDL cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted FG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR-BMA analysis
Number of subjects: 0
Study: 35639365

Group type: EXPERIMENTAL
Intervention: Coffee (2 cups per day, total amount 160 mg caffeine)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Green Tea (3 cups per day, total amount 252 mg catechin and 96 mg caffeine)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Herbal Tea (placebo, 3 cups per day)
Number of subjects: 48
Study: 33596746

Group type: EXPERIMENTAL
Intervention: Lactulose 15 mL once daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sennosides two tablets daily
Number of subjects: 100
Study: 32600454

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (Nebido®)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 36266481

Group type: EXPERIMENTAL
Intervention: 10-ml 0.5% bupivacaine without epinephrine
Number of subjects: 70

Group type: COMPARATOR
Intervention: 10 ml of 0.9% saline (control)
Number of subjects: 70
Study: 33797983

Group type: EXPERIMENTAL
Intervention: Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 35960116

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 42
Study: 34425346

Group type: EXPERIMENTAL
Intervention: Ultrasound-MRI fusion combined with contrast-enhanced ultrasound (Observation group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 39
Study: 32723753

Group type: EXPERIMENTAL
Intervention: Gradual antipsychotic reduction and discontinuation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 0
Study: 35868433

Group type: EXPERIMENTAL
Intervention: 800 mg NVCM intravenously every 12 h and 16 mg NVCM intrathecal administration every 24 h
Number of subjects: 29

Group type: COMPARATOR
Intervention: 800 mg NVCM intravenously every 12 h (Control)
Number of subjects: 29
Study: 33649919

Group type: EXPERIMENTAL
Intervention: Initial use of oral sodium alginate (arm A)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Late use of oral sodium alginate (arm B)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Water as control (arm C)
Number of subjects: 94
Study: 32723991

Group type: EXPERIMENTAL
Intervention: Two-weekly docetaxel for 8 cycles
Number of subjects: 10
Study: 35411939

Group type: EXPERIMENTAL
Intervention: SOC + AAP (Abiraterone acetate 1000 mg + Prednisolone 5 mg)
Number of subjects: 1003

Group type: COMPARATOR
Intervention: SOC-alone (Standard-of-care androgen deprivation therapy)
Number of subjects: 1003
Study: 36224521

Group type: EXPERIMENTAL
Intervention: Positive GDM status
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: One unit (kg) increase in birth weight
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: Positive GDM status (multivariate model)
Number of subjects: 858

Group type: EXPERIMENTAL
Intervention: Macrosomia status (multivariate model)
Number of subjects: 858
Study: 32639561

Group type: EXPERIMENTAL
Intervention: Behavioral Therapy (BT)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: BT to Zolpidem (second-stage therapy)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: BT to Cognitive Therapy (CT) (second-stage therapy)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Zolpidem to Trazodone (second-stage therapy)
Number of subjects: 211
Study: 33161159

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy
Number of subjects: 7750

Group type: EXPERIMENTAL
Intervention: Newly-prescribed medical therapy
Number of subjects: 7750
Study: 33685044

Group type: EXPERIMENTAL
Intervention: Single-lumen endotracheal intubation (group D)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Double-lumen endotracheal intubation (group S)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Coopdech occlusion of bronchial catheter combined with single-lumen endotracheal intubation (group C)
Number of subjects: 180
Study: 33321778

Group type: EXPERIMENTAL
Intervention: Co-induction technique (4% sevoflurane followed by 0.75 mg/kg propofol)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sevoflurane (8% with 100% oxygen at 8 L/min)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Propofol (1.5 mg/kg)
Number of subjects: 105
Study: 33167849

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study: 33115480

Group type: EXPERIMENTAL
Intervention: 20% or 80% assistance for foot clearance (FC)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 20% or 80% assistance for stability during stance (SS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 20% or 80% assistance for weight shift (WS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Baseline trial (no assistance)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Assistance for leading limb angle subtask (via FC assistance)
Number of subjects: 9
Study: 35609929

Group type: EXPERIMENTAL
Intervention: Exome sequencing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genome sequencing
Number of subjects: 0
Study: 34324100

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone intravenously (IV) preoperatively
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone from a nebulizer mask preoperatively
Number of subjects: 105

Group type: COMPARATOR
Intervention: Nebulised normal saline
Number of subjects: 105
Study: 34143199

Group type: EXPERIMENTAL
Intervention: Sonic activation of desensitizing agent (DA) containing 5% potassium nitrate and 2% sodium fluoride, activated for 30 seconds per tooth.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Desensitizing agent (DA) without sonic activation, applied for 10 minutes.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both treatments (SA and noSA)
Number of subjects: 34
Study: 32772509

Group type: EXPERIMENTAL
Intervention: Web-based educational support intervention (eHES)
Number of subjects: 438

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 438
Study: 36445624

Group type: EXPERIMENTAL
Intervention: Genotype-guided (GG) escalation of P2Y12 inhibitor therapy post PCI
Number of subjects: 539

Group type: COMPARATOR
Intervention: Control group (non-GG strategy)
Number of subjects: 539
Study: 34510193

Group type: EXPERIMENTAL
Intervention: Folic Acid (FA) supplementation (5 mg/d for 12 weeks)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 36364727

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control beverage (prune juice: CON)
Number of subjects: 16
Study: 35841243

Group type: EXPERIMENTAL
Intervention: Adenosine Triphosphate (ATP) infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33631132

Group type: EXPERIMENTAL
Intervention: Irie Classroom Toolbox intervention
Number of subjects: 865

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 865
Study: 36327309

Group type: EXPERIMENTAL
Intervention: Rectal progesterone suppository
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36231251

Group type: EXPERIMENTAL
Intervention: HIIT with BFR during interval (I)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HIIT with BFR during exercise (E)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: HIIT (H)
Number of subjects: 72

Group type: COMPARATOR
Intervention: No-training control (C)
Number of subjects: 72
Study: 34693504

Group type: EXPERIMENTAL
Intervention: Avelumab plus best supportive care (BSC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avelumab plus BSC
Number of subjects: 0

Group type: COMPARATOR
Intervention: PD-L1-guided strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avelumab strategy
Number of subjects: 0
Study: 33339976

Group type: COMPARATOR
Intervention: Conventional impression (Polyether)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cerec digital scan
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: iTero digital scan
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lava digital scan
Number of subjects: 10
Study: 34887528

Group type: EXPERIMENTAL
Intervention: Intranasal 24IU oxytocin
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 34461991

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise + vitamin D Supplementation (AE + VitD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitamin D Supplementation (VitD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 40
Study: 36341537

Group type: EXPERIMENTAL
Intervention: Frequency item response options on depression and generalized anxiety scales
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Severity item response options on depression and generalized anxiety scales
Number of subjects: 0
Study: 34016346

Group type: EXPERIMENTAL
Intervention: Ice slurry (4 g⋅kg ‐1 body weight, 0.5 °C)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control beverage (28 °C)
Number of subjects: 7
Study: 35779189

Group type: EXPERIMENTAL
Intervention: NX210 (0.4, 1.25, 2.5, 5, and 10 mg/kg)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: NX210
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33735709

Group type: EXPERIMENTAL
Intervention: Baclofen 75 mg/day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Baclofen 30 mg/day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 32667858

Group type: EXPERIMENTAL
Intervention: Mobile health application + routine medical care (app group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine medical care (control group)
Number of subjects: 100
Study: 35422611

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (1.5 mg/kg bolus before anesthesia induction, followed by 2.0 mg/kg/h continuous infusion until end of surgery)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control (0.9% saline at the same time points)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control
Number of subjects: 195
Study: 32863142

Group type: EXPERIMENTAL
Intervention: Chloride-rich intravenous fluid (0.9% saline)
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: Preoperative SCl−
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass duration
Number of subjects: 1056
Study: 32178950

Group type: EXPERIMENTAL
Intervention: Lavender essential oil
Number of subjects: 75

Group type: COMPARATOR
Intervention: Grape seed oil (control)
Number of subjects: 75
Study: 36579554

Group type: EXPERIMENTAL
Intervention: US-guided corticosteroid injections combined with a personalized rehabilitation program (Group A; n: 19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: US-guided corticosteroid injections alone (Group B; n: 18)
Number of subjects: 37
Study: 33359269

Group type: EXPERIMENTAL
Intervention: Single fraction of 19 Gy
Number of subjects: 170

Group type: COMPARATOR
Intervention: Two fractions of 13.5 Gy one week apart
Number of subjects: 170
Study: 33407549

Group type: EXPERIMENTAL
Intervention: WASH hardware provision and behavior change promotion
Number of subjects: 0
Study: 35107855

Group type: EXPERIMENTAL
Intervention: Ayahuasca (average 1.58 mg/ml DMT) in healthy volunteers
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ayahuasca (average 0.680 mg/ml DMT) in volunteers with SAD
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo in healthy volunteers
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo in volunteers with SAD
Number of subjects: 37
Study: 33646286

Group type: EXPERIMENTAL
Intervention: Intermittent pulse oximetry (every 4 hours, n = 114)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Continuous pulse oximetry (n = 115)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Intermittent pulse oximetry
Number of subjects: 229

Group type: COMPARATOR
Intervention: Continuous pulse oximetry
Number of subjects: 229
Study: 32455019

Group type: EXPERIMENTAL
Intervention: Daily ingestion of 60 mg iron and 0.4 mg folic acid
Number of subjects: 277
Study: 34170518

Group type: EXPERIMENTAL
Intervention: Mild-intensity physical exercise for 8 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 22
Study: 32779607

Group type: EXPERIMENTAL
Intervention: Airborne-particle abrasion (AA)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Hydrofluoric acid etching (HA)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Silane coupling agent application (SL)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: AA/SL
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: HA/SL
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: AA/HA
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: AA/HA/SL
Number of subjects: 4

Group type: COMPARATOR
Intervention: No surface treatment (C)
Number of subjects: 4
Study: 33856973

Group type: EXPERIMENTAL
Intervention: Forgiveness therapy
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Mindfulness-based schema (MBS) therapy
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study: 33600915

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Baricitinib 1 mg
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 33727005

Group type: EXPERIMENTAL
Intervention: Biodegradable-polymer sirolimus-eluting stents (BP-SES)
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Durable-polymer everolimus-eluting stents (DP-EES)
Number of subjects: 1300
Study: 32611638

Group type: EXPERIMENTAL
Intervention: Thymectomy plus prednisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 0
Study: 36060196

Group type: EXPERIMENTAL
Intervention: 1WS (once-weekly support by specialized therapists)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: 1W/1BD-S (once-weekly support supplemented with one-business-day response to emails)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: 1WC (once-weekly support by therapists in community clinics)
Number of subjects: 675

Group type: COMPARATOR
Intervention: 1WS
Number of subjects: 675

Group type: COMPARATOR
Intervention: 1W/1BD-S
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: 1WS, 1W/1BD-S, 1WC
Number of subjects: 675

Group type: COMPARATOR
Intervention: 1WC
Number of subjects: 675
Study: 33386238

Group type: EXPERIMENTAL
Intervention: Mental fatigue (30-min Stroop test)
Number of subjects: 25
Study: 36328912

Group type: EXPERIMENTAL
Intervention: Active distraction (tablet)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 99
Study: 33961295

Group type: EXPERIMENTAL
Intervention: Structured supervised exercise program (Group 1, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Telerehabilitation program (Group 2, n = 15)
Number of subjects: 30
Study: 32394772

Group type: EXPERIMENTAL
Intervention: BMI + SP app intervention (Study 1)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: BMI + SP app intervention (Study 2)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Control group (Study 2)
Number of subjects: 379
Study: 33414526

Group type: EXPERIMENTAL
Intervention: One-step phacotrabeculectomy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Two-step phacotrabeculectomy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 60
Study: 32947558

Group type: EXPERIMENTAL
Intervention: Vancomycin pharmacokinetic model incorporating time‐varying creatine clearance (CrCL)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Bayesian estimation with at least one measured serum concentration and frequent CrCL monitoring
Number of subjects: 213
Study: 36217626

Group type: EXPERIMENTAL
Intervention: Real acupuncture and exercise training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham acupuncture and exercise training
Number of subjects: 70
Study: 33098672

Group type: EXPERIMENTAL
Intervention: Perinatal Problem Identification Program
Number of subjects: 2558

Group type: EXPERIMENTAL
Intervention: Patient-associated factors
Number of subjects: 2558

Group type: EXPERIMENTAL
Intervention: Health personnel-associated factors
Number of subjects: 2558
Study: 35485835

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Social Anxiety (CBT-SA)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Cognitive Remediation (CR)
Number of subjects: 96
Study: 32835417

Group type: EXPERIMENTAL
Intervention: Zoledronate treatment
Number of subjects: 1000
Study: 32739319

Group type: EXPERIMENTAL
Intervention: XP‐RT (adjuvant concurrent chemo‐radiotherapy)
Number of subjects: 440

Group type: COMPARATOR
Intervention: XP (chemotherapy alone)
Number of subjects: 440
Study: 35654577

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 3185
Study: 32396700

Group type: EXPERIMENTAL
Intervention: Oral PrEP initiation
Number of subjects: 7830

Group type: EXPERIMENTAL
Intervention: PrEP users
Number of subjects: 7830

Group type: COMPARATOR
Intervention: PrEP initiation across randomized groups
Number of subjects: 7830
Study: 35300930

Group type: EXPERIMENTAL
Intervention: AIM for Teen Moms intervention
Number of subjects: 295
Study: 34282831

Group type: EXPERIMENTAL
Intervention: Needle-assisted injections
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cannula-assisted injections
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (baseline)
Number of subjects: 42
Study: 35987532

Group type: EXPERIMENTAL
Intervention: COPE
Number of subjects: 81

Group type: COMPARATOR
Intervention: RP
Number of subjects: 81
Study: 36368760

Group type: EXPERIMENTAL
Intervention: Induction of labour at 38+0 to 38+4 weeks' gestation
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Standard care as per each hospital trust (median gestation of delivery 39+4)
Number of subjects: 4000
Study: 33769675

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 1065

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 1065

Group type: EXPERIMENTAL
Intervention: Ertugliflozin
Number of subjects: 1065

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1065

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1065
Study: 35228574

Group type: EXPERIMENTAL
Intervention: Male infants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Female infants
Number of subjects: 0
Study: 32438301

Group type: EXPERIMENTAL
Intervention: Juice group (liquid enriched with carbohydrate and protein)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (200 mL of inert solution)
Number of subjects: 80
Study: 35694970

Group type: EXPERIMENTAL
Intervention: Schroth-based three-dimensional exercises (SBEG)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Postural corrective exercises (PCEG)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 63
Study: 33597589

Group type: EXPERIMENTAL
Intervention: High dose vitamin D3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35980634

Group type: EXPERIMENTAL
Intervention: Probabilistic opioid risk tool
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Narrative-enhanced probabilistic risk tool
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 36
Study: 34534529

Group type: EXPERIMENTAL
Intervention: Blalock‐Taussig shunts (mBTS)
Number of subjects: 544

Group type: COMPARATOR
Intervention: Right ventricle‐to‐pulmonary artery (RV‐PA) shunts
Number of subjects: 544
Study: 32820551

Group type: EXPERIMENTAL
Intervention: Life review writing
Number of subjects: 24

Group type: COMPARATOR
Intervention: Painting (active control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Coffee from around the world (active control)
Number of subjects: 24
Study: 35460725

Group type: EXPERIMENTAL
Intervention: 20% albumin (0.5-1.0 g/kg over 3 hours)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plasmalyte (30 ml/kg over 3 hours)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 20% albumin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Plasmalyte
Number of subjects: 100
Study: 34672159

Group type: EXPERIMENTAL
Intervention: Personalized - exercise training (ET) for 12 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional cardiac rehabilitation without ET for 12 weeks
Number of subjects: 20
Study: 33399254

Group type: EXPERIMENTAL
Intervention: Abemaciclib added to adjuvant endocrine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant endocrine therapy alone
Number of subjects: 0
Study: 33481463

Group type: EXPERIMENTAL
Intervention: Telehealth exercise intervention (functional circuit exercise training via videoconferencing, 3 times weekly for 12 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Delayed entry control group
Number of subjects: 80
Study: 34138863

Group type: EXPERIMENTAL
Intervention: Single STH infection
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Mild STH infection
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Younger children
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: None of the examined variables
Number of subjects: 393
Study: 35554515

Group type: EXPERIMENTAL
Intervention: Silastic ring laparoscopic Roux‐en‐Y gastric bypass (SR‐LRYGB)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 114